Literature DB >> 24783267

Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients.

Wenyuan Wang, Yaoping Li, Xin Zhang, Jiexian Jing, Xianwen Zhao, Yan Wang, Cunzhi Han.   

Abstract

OBJECTIVE: To explore the clinical significance of expression of CEA mRNA and serum CEA and the related proteins in colorectal cancer (CRC).
METHODS: Blood samples were collected from 370 CRC patients and 350 controls. CEA mRNA was determined by RT-PCR and levels of CEA, CA19-9, CA242, and CA724 were examined with chemiluminescence.
RESULTS: The positive rate of jointly detecting serum CEA, CA19-9, CA242, and CA724 was significantly higher than CEA mRNA expressions (P < 0.01), both positive rates were significantly correlated with TNM stage, lymph node, and visceral metastasis. The positive rate of jointly detecting in patients with poorly differentiated tumor was significantly higher than that in patients with highly differentiated tumor (P < 0.01). By contrast, CEA mRNA expression was not related with histopathologic grading. Postoperative follow-up found that all patients with high levels of CEA mRNA and serum CEA and the related proteins had liver, lung, pelvis, or other distant metastases.
CONCLUSIONS: These results suggest that high expressions of CEA mRNA and high levels of serum CEA and the related proteins are associated with the incidence and advanced of CRC. In addition, joint detection of serum CEA and the related proteins is more sensitivity than examination of serum CEA mRNA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24783267     DOI: 10.1002/jso.23503

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  Clinical role of circulating miR-223 as a novel biomarker in early diagnosis of cancer patients.

Authors:  Xiaoying Zhou; Guoping Ji; Han Chen; Wujuan Jin; Chengqiang Yin; Guoxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Development of a novel model for predicting survival of patients with spine metastasis from colorectal cancer.

Authors:  Yujie Liu; Minglei Yang; Bo Li; Kehan Xu; Xin Gao; Jialin Li; Haifeng Wei; Quan Huang; Wei Xu; Jianru Xiao
Journal:  Eur Spine J       Date:  2019-01-18       Impact factor: 3.134

Review 3.  Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.

Authors:  Xinzhi Miao; Fang Wang; Tianyun Wang; Siti Razila Abdul Razak; Muhammad Amir Yunus; Ida Shazrina Ismail
Journal:  3 Biotech       Date:  2021-09-01       Impact factor: 2.893

Review 4.  Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.

Authors:  Maria Smolle; Stefan Uranitsch; Armin Gerger; Martin Pichler; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2014-08-12       Impact factor: 5.923

5.  Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter.

Authors:  Ana R Rama; Rosa Hernandez; Gloria Perazzoli; Miguel Burgos; Consolación Melguizo; Celia Vélez; Jose Prados
Journal:  Int J Mol Sci       Date:  2015-06-04       Impact factor: 5.923

Review 6.  Colorectal Cancer Immunotherapy: Options and Strategies.

Authors:  Nor Adzimah Johdi; Nur Fazilah Sukor
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

Review 7.  Tissue Specific Promoters in Colorectal Cancer.

Authors:  A R Rama; A Aguilera; C Melguizo; O Caba; J Prados
Journal:  Dis Markers       Date:  2015-11-15       Impact factor: 3.434

8.  Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.

Authors:  Shufang Ning; Wene Wei; Jilin Li; Bingbing Hou; Jianhong Zhong; Yuxuan Xie; Haizhou Liu; Xianwei Mo; Jiansi Chen; Litu Zhang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

9.  TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer.

Authors:  Cong Zhou; Ranran Pan; Haochang Hu; Bin Li; Jie Dai; Xiuru Ying; Hang Yu; Jie Zhong; Yiyi Mao; Yihan Zhang; Dongping Wu; Shiwei Duan
Journal:  PeerJ       Date:  2018-09-13       Impact factor: 2.984

10.  Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer.

Authors:  Ning Yang; Feng Qiu; Feng Zhu; Lei Qi
Journal:  Int J Nanomedicine       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.